Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2025-12-30 @ 12:46 PM
Study NCT ID:
NCT06313268
Status:
COMPLETED
Last Update Posted:
2024-10-10
First Post:
2024-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety of Effivia®, a Bevacizumab Biosimilar
Sponsor:
Laboratorios Liomont
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-02
Completion Date Type:
ACTUAL
First Submit Date:
2024-02-21
First Submit QC Date:
None
Study First Post Date:
2024-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-10-10
Last Update Post Date Type:
ACTUAL